DPIIT recognised startup Government of India
Startup India
Galoretx Pharmaceuticals Private Limited - life sciences in Udupi, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹2.52 Cr
▲ 41% YoY
Net profit · FY 2024
₹20.61 Lakh
Net margin 8.2%
EBITDA · FY 2024
₹31.46 Lakh
EBITDA margin 12.5%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹1.8 Cr
Secured borrowings
Company age
8 yrs
Est. 2018
Employees · EPFO
10
Provident fund records
About Galoretx Pharmaceuticals Private Limited
Data last updated:
Galoretx Pharmaceuticals Private Limited is a private limited company based in Udupi, Karnataka, India, recognised as a startup by DPIIT. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 12 July 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U85320KA2018PTC114735. Its GSTIN is 29AAHCG3940P1ZZ (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Raghuveer Kallajhari Ramachandra (Whole-Time Director) and Chenna Krishna Gundala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #1 – 1 – 16(S)1 Kallajhari, Udupi, Karnataka, India – 576102.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.52 Cr, a growth of 41% compared to the previous year. For the same year it recorded a net profit of ₹20.61 Lakh (net margin 8.2%) and EBITDA of ₹31.46 Lakh (EBITDA margin 12.5%). Revenue has grown at a compounded annual rate (CAGR) of 80% over three years and 82% over five years.
The company has about 10 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: GaloreTx. As per MCA filings, the company has open charges of ₹1.8 Cr on record.
Galoretx Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-26-0000404). For more details, the company can be reached via its website galoretx.com.
Company details
CIN U85320KA2018PTC114735
Registration Number 114735
Incorporation Date 12 July 2018
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-KR-26-0000404
Key People
Raghuveer Kallajhari Ramachandra Whole-Time Director Chenna Krishna Gundala Director Sasikumar Govindannair Pottayil Director Recognitions & Rankings of Galoretx Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-26-0000404
Contact details
Galoretx Pharmaceuticals Private Limited's registered office is in Udupi, Karnataka. Its website is galoretx.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address#1 – 1 – 16(S)1 Kallajhari, Udupi, Karnataka, India – 576102
- IndustryLife Sciences, Biotechnology
To see the full contact details of Galoretx Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Galoretx Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Galoretx Pharmaceuticals operates one associated brand: GaloreTx. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Peptide and peptide-based therapies are manufactured using conjugation techniques. | galoretx.com |
Business activity
The main business activity of Galoretx Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Galoretx Pharmaceuticals Private Limited, buy the company report.
Financials of Galoretx Pharmaceuticals Private Limited
FY 2025 filings availableGaloretx Pharmaceuticals Private Limited reported revenue of ₹2.52 Cr (up 41% YoY) for FY 2024.
Revenue · FY 2024
₹2.52 Cr ▲ 41%
Net profit · FY 2024
₹20.61 Lakh margin 8.2%
EBITDA · FY 2024
₹31.46 Lakh margin 12.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 41%
3 years · compounded
▲ 80%
5 years · compounded
▲ 82%
EBITDA CAGR growth
1 year
▼ 21%
3 years · compounded
▲ 106%
5 years · compounded
▲ 31%
Revenue has grown at a compounded annual rate (CAGR) of 82% over five years, including 41% growth in the latest year. EBITDA fell 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹31.46 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹20.61 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.5% | ||||
| Net Profit Margin | 8.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Galoretx Pharmaceuticals Private Limited, buy the company report.
Board of directors of Galoretx Pharmaceuticals Private Limited
Galoretx Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chenna Krishna Gundala Also directs: Peptis Pharma LLP | Director | 06 Feb 2023 | 3 Years 8 Months | Current |
| Raghuveer Kallajhari Ramachandra | Whole-Time Director | 12 Jul 2018 | 8 Years 3 Months | Current |
| Sasikumar Govindannair Pottayil Also directs: Peptis Pharma LLP, Peptyde TX Private Limited | Director | 06 Feb 2023 | 3 Years 8 Months | Current |
Auditor
Galoretx Pharmaceuticals Private Limited is audited by Pramod Krishna & Co. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Pramod Krishna & Co. | FY 2022 | 017958S |
Shareholding
The shareholding of Galoretx Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Galoretx Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.8 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Feb 2025 | 101063153 | Others | ₹1 Cr | Open | |
| 01 Aug 2024 | 100965615 | Others | ₹70.18 Lakh | Open | |
| 03 Oct 2022 | 100651103 | Others | ₹10 Lakh | Open |
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Galoretx Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Galoretx Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Galoretx Pharmaceuticals Private Limited has a workforce of 10 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.
Employee count
10
Active EPFO establishments
1
Employee growth
25%
GST
Galoretx Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAHCG3940P1ZZ | Karnataka | Active | 21 Aug 2018 |
To see the full GST registrations and return filing status of Galoretx Pharmaceuticals Private Limited, buy the company report.
Recent activity
Galoretx Pharmaceuticals Private Limited has 8 board changes on record since 2018: 4 appointments and 4 cessations. The latest: Chenna Krishna Gundala ceased to be Additional Director on 29 Sep 2023.
AGM
Galoretx Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Galoretx Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Charges
A charge with Others amounted to Rs. 100.00 Lakh with Charge ID 101063153 was registered on 25 Feb 2025.
Charges
A charge with Others amounted to Rs. 70.18 Lakh with Charge ID 100965615 was registered on 01 Aug 2024.
Ceased
Chenna Krishna Gundala ceased to be Additional Director.
Ceased
Sasikumar Govindannair Pottayil ceased to be Additional Director.
Appointed
Chenna Krishna Gundala was appointed as Director.
Appointed
Sasikumar Govindannair Pottayil was appointed as Director.
Charges
A charge with Others amounted to Rs. 10.00 Lakh with Charge ID 100651103 was registered on 03 Oct 2022.
Ceased
Kallajhari Subrahmanya Ramachandra ceased to be Director.
Ceased
Raghuveer Kallajhari Ramachandra ceased to be Director.
Appointed
Kallajhari Subrahmanya Ramachandra was appointed as Whole-Time Director.
2 earlier events are in the company report.
Frequently asked questions
Galoretx Pharmaceuticals is an active private limited company based in Udupi, Karnataka, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 12 July 2018 (8+ years old) and is registered under CIN U85320KA2018PTC114735.
Galoretx Pharmaceuticals has 3 current directors:
- Raghuveer Kallajhari Ramachandra - Whole-Time Director
- Chenna Krishna Gundala - Director
- Sasikumar Govindannair Pottayil - Director
The latest financial statements of Galoretx Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Galoretx Pharmaceuticals is 29AAHCG3940P1ZZ, registered in Karnataka.
The CIN (Corporate Identification Number) of Galoretx Pharmaceuticals is U85320KA2018PTC114735. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Galoretx Pharmaceuticals was incorporated on 12 July 2018, making it 8+ years old. It is registered with the Registrar of Companies, Bangalore.
Chenna Krishna Gundala ceased to be Additional Director on 29 Sep 2023. Sasikumar Govindannair Pottayil ceased to be Additional Director on 29 Sep 2023. Chenna Krishna Gundala was appointed as Director on 06 Feb 2023. Galoretx Pharmaceuticals has 8 board changes on record in total.
Yes, Galoretx Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Galoretx Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-26-0000404).
Galoretx Pharmaceuticals can be reached through the website galoretx.com. Its registered office is in Udupi, Karnataka, India.